CPT2 and cancer: Our results show that cancer tissues down-regulate the expression of CPT2 and that higher expression of CPT2 in cancer tissue independently predicts better prognosis in CRC patients, indicating the important role of fatty acid oxidation, especially CPT2, in cancer progression.